Skip to main content

VGM & ASSOCIATESHealthcare MSO

Search GO

Search GO

VGM & ASSOCIATESHealthcare MSO LEARN ABOUT VGM

[BREAKING NEWS] The DMEPOS Relief Act of 2023 is Introduced in the House

Published in Government Relations on September 19, 2023

New legislation was introduced by Representatives Mariannette Miller-Meeks (R-IA) and Paul Tonko (D-NY). H.R. 5555, The DMEPOS Relief Act of 2023, provides a 90/10 blended Medicare reimbursement rate (90% adjusted payment rate/10% unadjusted fee schedule rate) for most home medical equipment products in competitive bidding areas (CBAs), effective Jan. 1, 2024, through Dec. 31, 2024. There is also language in section 3 of the legislation to extend the current 75/25 blended rate in effect for non-rural/non-CBA suppliers through 2024.

MMM at CarePro "We appreciate Rep. Miller-Meeks for her unwavering commitment to improving healthcare access for our seniors," said Danielle Schwiebert, Executive Director, CarePro Health Services. "The legislation for the DMEPOS Relief Act is a significant step forward in ensuring that vital medical equipment and services remain accessible to those who need them most. At CarePro Health Services, we stand in strong support of this initiative, as it aligns perfectly with our mission to provide high-quality care and support to our patients."

None of this would have been possible without the dedicated efforts of MAMES and the other state associations, VGM Government Relations, and AAHomecare. Their tireless work in building grassroots relationships and advocating for this legislation has been instrumental in its introduction. Pictured above is Rep. Miller-Meeks at CarePro, a great example of grassroots in action. This also demonstrates the immense power of grassroots initiatives in driving legislative change. Through their tenacity and unwavering commitment, they have shown how meaningful connections with communities can lead to tangible improvements in healthcare accessibility.

"We are so grateful for Rep. Miller-Meeks’ recognition of the critical need to extend relief for the HME industry,” said Rose Schafhauser, Executive Director, MAMES. “We appreciate her proactive stance in introducing this legislation in the House, a move that will empower our members in the Midwest to continue improving their communities.”

“This is a great first step, and we are thankful for Rep. Miller-Meeks and her leadership, and we are thankful to our members for their work thus far,” said Mike Isaacson, SVP of Government Relations, VGM & Associates. “However, there is still a great deal of work to be done. Now is the time to double down on our efforts. We need all our members to reach out to their representatives and ask for their support on this bill. This will take an industry focus to get H.R. 5555 across the finish line.”

Message Your Representative

From Our Experts

Proposed Rule Suggests Significant Change To Accreditation Process thumbnail

Proposed Rule Suggests Significant Change To Accreditation Process The recently released proposed rule CMS-1828-P contains a significant change that could reshape how suppliers navigate accreditation. The rule proposes a major change that would require suppliers to be surveyed and reaccredited annually instead of the current three (3) year cadence. This proposal raises substantial questions about both operational feasibility and cost implications.

August Of Action: Your Chance To Connect With Congress thumbnail

August Of Action: Your Chance To Connect With Congress It's time to take advantage of August Of Action—a perfect opportunity to make your voice heard. Every summer, federal legislators return to their home states during the Congressional recess. While it gives them a break from Washington D.C., it's primarily a time for them to connect with constituents like you.

HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail

HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry.

CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail

CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu

Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail

Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk.

Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail

Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review.

Evaluating the Value of a Payer Contract thumbnail

Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort.

Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT. The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement.

Give your business an advantage over the competition.

Become a Member